Cellectis Unveils a Non-Viral Gene Therapy Approach for Sickle Cell Disease in Nature Communications
NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to ...
Healthy Living with USA Health: Comprehensive Sickle Cell Center provides life changing Gene Therapy
MOBILE, Ala. (WALA) - Gene therapy for sickle cell disease (SCD) is a cutting-edge treatment that targets the root cause of the disorder—a genetic mutation in the HBB gene, which leads to the ...
A study finds sickle cell trait in babies is linked to distinct molecular markers detectable within the first week after birth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results